← Back to Screener
McKesson Corporation (MCK)
Price$775.66
Value ScoreD
Growth ScoreB
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-19.89%
Price vs S&P 500 (4W)5.39%
VGM Score55.56
Market Capitalization$93.24B
P/E Ratio (Annual)19.58x
Indicated Dividend Yield (Annual)0.43%
All Metrics
P/CF (Annual)15.15x
Book Value / Share (Quarterly)$36.58
P/TBV (Annual)11.28x
Indicated Dividend (Annual)$3.28
Revenue Growth (3Y)13.39%
Cash Flow / Share (Quarterly)$45.08
Payout Ratio (TTM)8.00%
Price vs S&P 500 (YTD)-13.60%
Gross Margin (TTM)3.60%
Net Profit Margin (TTM)1.18%
EPS (TTM)$38.44
10-Day Avg Trading Volume1.35M
EPS Excl Extra (TTM)$38.44
Revenue Growth (5Y)11.11%
EPS (Annual)$38.37
Dividend / Share (Annual)$3.11
ROI (Annual)7.21%
Gross Margin (Annual)3.60%
Net Profit Margin (5Y Avg)0.96%
Cash / Share (Quarterly)$33.13
P/E Basic Excl Extra (TTM)19.58x
Revenue Growth QoQ (YoY)6.02%
EPS Growth (5Y)39.07%
P/E Normalized (Annual)19.58x
ROA (Last FY)5.78%
Revenue Growth TTM (YoY)12.36%
EBITD / Share (TTM)$52.11
ROE (5Y Avg)17.95%
Operating Margin (TTM)1.54%
Cash Flow / Share (Annual)$45.08
P/B Ratio15.83x
P/B Ratio (Quarterly)4.06x
Net Income / Employee (Annual)$110,700
EV / Revenue (TTM)0.24x
Net Interest Coverage (TTM)113.75x
ROA (TTM)5.74%
EPS Growth QoQ (YoY)36.75%
EV / EBITDA (TTM)14.81x
EPS Incl Extra (Annual)$38.37
Current Ratio (Annual)0.85x
Quick Ratio (Quarterly)0.48x
3-Month Avg Trading Volume0.97M
52-Week Price Return9.00%
EV / Free Cash Flow (Annual)17.71x
P/E Incl Extra (TTM)19.58x
Revenue / Employee (TTM)$9,382,100
Tangible BV / Share (Quarterly)$17.76
P/S Ratio (Annual)0.23x
Asset Turnover (Annual)4.90x
52-Week High$999.00
Operating Margin (5Y Avg)1.26%
EPS Excl Extra (Annual)$38.37
CapEx CAGR (5Y)3.05%
Tangible BV CAGR (5Y)-15.75%
26-Week Price Return-11.97%
Quick Ratio (Annual)0.48x
13-Week Price Return-16.72%
Total Debt / Equity (Annual)1.45x
Current Ratio (Quarterly)0.85x
Enterprise Value$95.79B
Revenue / Share Growth (5Y)16.99%
Asset Turnover (TTM)4.86x
Book Value / Share Growth (5Y)-1.84%
Revenue / Employee (Annual)$9,382,100
Inventory Turnover (Annual)16.48x
Pretax Margin (Annual)1.54%
Cash / Share (Annual)$33.13
3-Month Return Std Dev26.15%
Gross Margin (5Y Avg)4.15%
Net Income / Employee (TTM)$110,700
EBITDA CAGR (5Y)9.08%
EBITDA Interim CAGR (5Y)15.17%
ROE (Last FY)17.67%
Net Interest Coverage (Annual)26.11x
EPS Basic Excl Extra (Annual)$38.37
P/FCF (TTM)14.31x
Receivables Turnover (TTM)15.05x
EV / Free Cash Flow (TTM)17.71x
Total Debt / Equity (Quarterly)1.29x
EPS Incl Extra (TTM)$38.44
Receivables Turnover (Annual)16.26x
ROI (TTM)16.23%
Dividend Growth Rate (5Y)12.51%
P/S Ratio (TTM)0.23x
Pretax Margin (5Y Avg)1.28%
Revenue / Share (Annual)$3250.85
Tangible BV / Share (Annual)$11.95
Forward P/E16.41x
Free OCF CAGR (5Y)6.76%
Price vs S&P 500 (52W)-15.36%
P/E Ratio (TTM)19.58x
EPS Growth TTM (YoY)48.91%
Year-to-Date Return-5.44%
5-Day Price Return5.56%
EPS Normalized (Annual)$38.37
ROA (5Y Avg)4.42%
Net Profit Margin (Annual)1.18%
Month-to-Date Return4.47%
Cash Flow / Share (TTM)$31.05
EBITD / Share (Annual)$52.12
EPS Growth (3Y)15.30%
Operating Margin (Annual)1.54%
LT Debt / Equity (Annual)1.21x
P/CF (TTM)15.15x
ROI (5Y Avg)9.37%
P/E Excl Extra (TTM)19.58x
LT Debt / Equity (Quarterly)0.99x
EPS Basic Excl Extra (TTM)$38.44
P/TBV (Quarterly)8.36x
Payout Ratio (Annual)8.00%
P/B Ratio (Annual)4.29x
Dividend / Share (TTM)$3.11
Inventory Turnover (TTM)16.48x
Pretax Margin (TTM)1.54%
Book Value / Share (Annual)$31.43
Price vs S&P 500 (13W)-24.97%
Net Margin Growth (5Y)18.73%
Dividend Yield (TTM)0.41%
Beta0.31x
P/FCF (Annual)17.23x
Revenue / Share (TTM)$3282.59
ROE (TTM)39.43%
52-Week Low$637.00
vGradeD
gGradeB
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q4 2611.69est. 11.68
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.18
4.18
4.18
4.22
Industry Peers — Drug Wholesale(9)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MCKMcKesson Corporation | D | B | C | $775.66 |
| CORCencora, Inc. | D | B | C | $275.04 |
| CAHCardinal Health, Inc. | C | C | B | $205.71 |
| HLFHerbalife Ltd. | B | D | C | $11.43 |
| NUSNuSkin Enterprises, Inc. | A | F | D | $5.37 |
| COSMCosmos Holdings Inc. Common Stock | C | B | D | $0.25 |
| ZSTKZeroStack Corp. Common Stock | — | F | D | $4.82 |
| WGRXWellgistics Health, Inc. Common Stock | D | F | D | $4.35 |
| HWHHWH International Inc. Common Stock | F | F | D | $1.04 |
| HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares | — | F | D | $0.49 |
About
McKesson Corp is one of three dominant pharmaceutical wholesalers in the United States, controlling a significant portion of the pharmaceutical distribution market alongside Cencora and Cardinal Health. The company sources and distributes branded, generic, and specialty pharmaceuticals to retail pharmacies, independent pharmacies, hospitals, and healthcare providers, while also supplying medical-surgical products and equipment to healthcare facilities. McKesson maintains operations in Canada for pharmaceutical distribution and offers technology solutions to pharmacy customers.